A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

April 9, 2024

Study Completion Date

April 9, 2024

Conditions

Covid-19

Interventions

DRUG

nirmatrelvir, ritonavir

single cohort

Trial Locations (3)

King Abdulaziz Medical City, Riyadh

King Faisal Specialist Hospital & research center - Jeddah, Jeddah

King Faisal Specialist Hospital and Research Center, Riyadh